Nektar Therapeutics Nektar (NASDAQ: NKTR) Inks Collaboration And Supply Agreement With Merck Nektar Therapeutics (NASDAQ: NKTR) disclosed that it has signed a clinical study partnership and supply agreement with Merck & Co. (NYSE: MRK).
